Global Leader Award for clinical trials eligibility, a reissued program aligned with policy.
Supporting early-career researchers from low- and middle-income countries for 3-5 years to conduct mentor-led research projects relevant to their country's health priorities.
The Emerging Global Leader Award (K43) funds mentored research and career development for LMIC junior faculty, supporting projects that advance global health and foster future research leaders at LMIC institutions.
The Beeson award supports early-stage clinician-scientists in developing aging research and leadership skills, without leading an independent clinical trial.
Emerging Leader Award supports rising scientific leaders with proof-of-concept research funding to advance diagnostics, therapies, and other patient-focused solutions for Lyme and other tick-borne diseases.
NHLBI plans to fund single-site clinical trials (R61/R33) testing therapeutic, behavioral, or prevention strategies, encouraging innovative designs.